Skip to content

A study of tramadol in improving depression and anxiety of female patients undergoing elective surgery

A study of tramadol in improving depression and anxiety of female patients undergoing elective surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045898
Enrollment
Unknown
Registered
2021-04-27
Start date
2021-04-25
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressed pain

Interventions

Tramadol group :Tramadol+Sufentanil

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18-65 years. 2. Patients undergoing elective laparoscopic surgery, and the operation time is less than 6 hours. 3. ASA I-III level. 4. 18.5<= Body mass index (BMI) <= 28. 5. Voluntary signed anesthesia consent form and postoperative patient-controlled intravenous analgesia informed consent form. 6. Volunteer to participate and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pstients with chronic pain, long-term use of analgesics, psychotropic drugs (including opioids, NSAIDs, sedatives, and antidepressants), alcohol abusers; 2. Patients with serious diseases such as heart, nausea, liver, kidney and blood system; 3. Allergies, or history of allergies to opioids, tramadol, and Kaifen; 4. Take monoamine oxidase inhibitor drugs within 15 days; 5. Pregnant or parturient; 6. Participated in other drug trials within three months; 7. No night shift a week before surgery, disturbance of work and rest, travel history in different time zones, insomnia, anxiety, etc.

Design outcomes

Primary

MeasureTime frame
Baker depression scale score;Self-rating anxiety scale score;Chinese version of charlize sleep questionnaire score;

Secondary

MeasureTime frame
Oxygen saturation;Heart rate;Blood pressure;Pain NRS score;Postoperative ambulation time;Hospitalization Duration;Analgesic satisfaction;Nausea and vomiting;The PCA compressions after operation;The dose of PCA;

Countries

China

Contacts

Public ContactHuang He

The Second Affiliated Hospital of Chongqing Medical University

cooldgy3344@126.com+86 13708385559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026